Wall Street brokerages forecast that LifePoint Health Inc (NASDAQ:LPNT) will report earnings per share of $0.82 for the current quarter, Zacks Investment Research reports. Nine analysts have provided estimates for LifePoint Health’s earnings. The lowest EPS estimate is $0.75 and the highest is $0.91. LifePoint Health reported earnings of $1.09 per share in the same quarter last year, which suggests a negative year-over-year growth rate of 24.8%. The business is expected to issue its next quarterly earnings report on Friday, February 16th.
According to Zacks, analysts expect that LifePoint Health will report full year earnings of $3.68 per share for the current fiscal year, with EPS estimates ranging from $3.56 to $4.01. For the next financial year, analysts anticipate that the firm will report earnings of $4.01 per share, with EPS estimates ranging from $3.53 to $4.60. Zacks’ EPS averages are a mean average based on a survey of sell-side research firms that that provide coverage for LifePoint Health.
LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Friday, October 27th. The company reported $0.80 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.95 by ($0.15). The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.60 billion. LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The company’s revenue was down .7% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.94 EPS.
LPNT has been the subject of several recent research reports. Citigroup dropped their price target on LifePoint Health from $70.00 to $60.00 and set a “buy” rating for the company in a research report on Monday, October 30th. Robert W. Baird set a $55.00 price target on LifePoint Health and gave the stock a “buy” rating in a research report on Monday, October 30th. Piper Jaffray Companies reiterated a “hold” rating and issued a $66.00 price target on shares of LifePoint Health in a research report on Wednesday, October 4th. SunTrust Banks set a $60.00 target price on LifePoint Health and gave the company a “hold” rating in a research report on Thursday, October 12th. Finally, KeyCorp restated a “hold” rating on shares of LifePoint Health in a research report on Sunday, October 29th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have assigned a buy rating to the company. LifePoint Health presently has a consensus rating of “Hold” and a consensus price target of $59.14.
LifePoint Health (LPNT) opened at $48.25 on Friday. The company has a market capitalization of $1,900.00, a PE ratio of 11.43, a P/E/G ratio of 1.14 and a beta of 0.67. LifePoint Health has a 12-month low of $42.50 and a 12-month high of $70.95. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.85 and a quick ratio of 1.65.
LifePoint Health announced that its board has authorized a stock buyback plan on Friday, October 27th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Shares buyback plans are typically a sign that the company’s board believes its stock is undervalued.
In other news, insider David M. Dill sold 45,000 shares of LifePoint Health stock in a transaction that occurred on Tuesday, January 16th. The shares were sold at an average price of $48.52, for a total transaction of $2,183,400.00. Following the completion of the sale, the insider now owns 252,673 shares of the company’s stock, valued at $12,259,693.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Marguerite Kondracke sold 3,907 shares of LifePoint Health stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $44.73, for a total transaction of $174,760.11. The disclosure for this sale can be found here. Insiders have sold 52,323 shares of company stock valued at $2,507,781 in the last ninety days. Insiders own 8.76% of the company’s stock.
Several institutional investors have recently bought and sold shares of the company. American Century Companies Inc. raised its stake in shares of LifePoint Health by 7.7% during the third quarter. American Century Companies Inc. now owns 3,630,487 shares of the company’s stock valued at $210,205,000 after acquiring an additional 260,944 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of LifePoint Health by 1.3% during the second quarter. Vanguard Group Inc. now owns 3,310,467 shares of the company’s stock valued at $222,299,000 after acquiring an additional 43,504 shares in the last quarter. State Street Corp raised its stake in shares of LifePoint Health by 2.1% during the second quarter. State Street Corp now owns 1,132,914 shares of the company’s stock valued at $76,075,000 after acquiring an additional 23,552 shares in the last quarter. Victory Capital Management Inc. raised its stake in shares of LifePoint Health by 19.3% during the third quarter. Victory Capital Management Inc. now owns 973,978 shares of the company’s stock valued at $56,393,000 after acquiring an additional 157,831 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its stake in LifePoint Health by 28.7% in the third quarter. Bank of New York Mellon Corp now owns 795,233 shares of the company’s stock worth $46,044,000 after buying an additional 177,329 shares in the last quarter.
COPYRIGHT VIOLATION WARNING: This piece of content was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/20/lifepoint-health-inc-lpnt-expected-to-announce-earnings-of-0-82-per-share.html.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Get a free copy of the Zacks research report on LifePoint Health (LPNT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.